Skip to content

Impact of Socioeconomic Inequalities in Transition Between Health, Multimorbidity and Death Amongst Older People

What is the Impact of Socioeconomic Inequalities in the Rates of Transition Between Health, Multimorbidity and Death Amongst Older People in England?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02609516
Enrollment
1300000
Registered
2015-11-20
Start date
2015-01-31
Completion date
2017-01-31
Last updated
2015-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity

Keywords

Multimorbidity, Health inequalities, Ageing, Mortality

Brief summary

Life expectancy at age 65 in the most deprived fifth of the English population was about 4 years shorter than of the most affluent fifth in 2010. The inverse gradient between mortality and social position is well established. But how disease patterns and multimorbidity (having two or more long term conditions at the same time) impact on differential mortality rates is inconclusive: is it because disadvantaged groups acquire more or more lethal combinations of, diseases over their life course; or, simply, become ill at ages younger than more affluent groups?

Detailed description

The association between social inequality and cause-specific mortality and single disease morbidity has been studied extensively. However, it remains unclear whether having two or more chronic diseases concurrently (or 'multimorbidity') plays a role in contributing to the inequalities gap in survival. This is particularly relevant given an ageing population and the trend of a widening in the life expectancy gap across several European countries. Multimorbidity incidence increases rapidly with age. Estimates of the prevalence of multimorbidity in older people range from 55% to 98%, mainly due to the selection of diseases included, population coverage (hospital, community) and data source (self-reported surveys or clinical records). However, across all studies there is a clear and consistent pattern of higher prevalence rates at older ages, with multimorbidity. Many aspects of the patient health trajectory remain under-explored. Patient case-mixes are likely to vary across socioeconomic groups, alongside a host of prognostic factors, including the clustering of multiple risk factors, age of onset, and disease presentation, progression and management in the presence of multiple health conditions.

Interventions

This study is based on the retrospective analysis of linked electronic health records.

Sponsors

University of Leeds
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Registered with a participating practice that has agreed to data linkage * Registered with an 'up to standard' participating general practice for at least 1 year * Aged 45 and over on Jan 1st 2001 or who turn 45 between 1st Jan 2001 and 25th March 2010, irrespective of initial health status.

Exclusion criteria

* Patients with a record unlinked to deprivation due to missing or incomplete postcode of residence.

Design outcomes

Primary

MeasureTime frameDescription
Yearly multimorbidity incidence rate10 yearsNumerator: Of patients with either 0 or 1 chronic diseases as on 1st Jan of the year, all those who become multimorbid by 31st Dec of the year. Denominator: patient years at risk of patients with either 0 or 1 chronic diseases as on 1st Jan of the year
Yearly multimorbidity prevalence10 yearsNumerator: all those with 2 or more listed diseases on 1st July of the year. Denominator: All eligible patients on 1st July of the year, irrespective of disease status on that date.
Yearly all-cause mortality rates10 yearsNumerator: number of deaths until 31st Dec of the year amongst the patients included in the denominator. Denominator: Person years at risk of patients with 0,1,2 or more diseases on 1st Jan of the year.
Overall life expectancy10 yearsIncident rates of transitions between no disease, 1 disease, 2+ diseases, and death.
Health state-specific life expectancies10 yearsIncident rates of transitions between four health states - no disease, 1 disease, 2+ diseases, and death.

Secondary

MeasureTime frameDescription
Yearly non-accidental mortality rates10 yearsAs outcome 3 but excluding accidental deaths from the numerator

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026